Metropolitan Kentjana Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Metropolitan Kentjana Tbk. trades at Rp21,750 (market cap 20.74T, 40.8K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Metropolitan Kentjana Tbk. is far larger — about 198.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MKPI | SCPI | |
|---|---|---|
Market Cap | 20.74T | 104.4B |
Volume | 40.8K | — |
Lot | 408 | — |
Turnover | 889.88M | — |
Average Price | 21,810.78 | — |
Value | 889.88M | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Metropolitan Kentjana Tbk was established based on notarial deed No. 38 dated March 29, 1972 of Hobropoerwanto, S.H. notary in Jakarta.
Read more on MKPI →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →